Cognetivity Neurosciences Ltd C.CGN

Alternate Symbol(s): CGNSF

Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial and consumer environments for potentially allowing early diagnosis of dementia. The Company’s ICA uses artificial intelligence and machine learning techniques to detect the earliest signs of cognitive impairment by testing the performance of brain. Its products include CognICA and OptiMind. The CognICA has various applications from providing a measure of cognitive function, to long-term health monitoring, corporate wellness, and personalized brain health. The OptiMind is a wellness app that measures individuals everyday cognitive performance. The Company serves various industries, including healthcare, elder care, enterprise, everyday use, and research. The ICA is available for clinical use in the United States of America, United Kingdom and Europe.

CSE:CGN - Post by User

Cognetivity Neurosciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by tinkvidon Oct 08, 2021 3:00pm

122 Views

Post# 33990009

FDA approval for Cognetivity's ICA

If CGN gets FDA approval for their ICA (integrated cognitive assessment tool) the share price will no longer be .68 cents.

CGN has made some pretty promising relationships as of late....

HOLD ON TIGHT

With Merck, Eli Lilly and Apple currently testing.....the Race is on!